FindTrial
Sign In

Study of Difluprednate in the Treatment of Uveitis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00501579
Enrollment
Unknown
Registered
2007-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2008-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Brief summary

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Interventions

DRUGDifluprednate
DRUGPrednisolone Acetate

Sponsors

Sirion Therapeutics, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
2 Years to No maximum

Inclusion criteria

* Diagnosis of endogenous anterior uveitis in at least 1 eye

Exclusion criteria

* Presence of intermediate uveitis, posterior uveitis or panuveitis * Corneal abrasion * Any confirmed or suspected active viral, bacterial, or fungal keratoconjunctival disease * Allergy to similar drugs, such as other corticosteroids

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 30, 2026